The federal government will revise its national vaccination program, limiting doses of AstraZeneca for those under 50 following concerns about the link between the vaccine and blood clots.

The federal government will revise its national vaccination program, limiting doses of AstraZeneca for those under 50 following concerns about the link between the vaccine and blood clots.